TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 4

Health Issues

IRA, innovation, drug pricing in federal programs, orphan drugs, PAPHA reauthorization, competitiveness, supply chain, vaccine access and coverage

Budget/Appropriations

Federal budget issues

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Taxation/Internal Revenue Code

vaccine policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.